Nav: Home

UC researchers examine potential drug pathway to combat pneumocystis

December 14, 2016

CINCINNATI--A study led by University of Cincinnati (UC) researchers is offering new insight in how the fungus Pneumocystis, thrives in the lungs of immune-compromised individuals, where it can cause a fatal pneumonia.

The study, "Functional characterization of the Pneumocystis carinii Inositol Transporter 1," is currently available in the online edition of the journal, MBio and details the use of mouse models to identify a new drug therapy for the potential treatment of Pneumocystis pneumonia.

Pneumocystis must transport inositol--a sugar-like nutrient essential for life in most organisms--obtained from the mammalian lung using a specific transporter, explains Melanie T. Cushion, PhD, senior associate dean for research and professor of internal medicine at the UC College of Medicine.

"Identifying a drug to inhibit the transporter will kill these fungi because they can't synthesize inositol as they lack two enzymes to do so," says Cushion. "The transporters in humans and Pneumocystis are sufficiently different that inhibitors of the fungal transporter are not likely to impact the mammalian transporters. If that's the case, no toxicity is expected with this new line of drugs."

These fungi are immune to common current anti-fungal therapies, and the gold standard therapy, trimethoprim sulfamethoxazole, often results in life-threatening allergic reactions in many patients. In the journal article, researchers characterized the transport of inositol in the fungus and found that it was highly selective for inositol and did not transport any other molecules, explains Cushion.

For individuals living with HIV/AIDS, Pneumocystis jirovecii, causes a lethal pneumonia (PCP) despite the use of combined antiretroviral therapy in patients, says Cushion. The mortality rate from PCP is about 15 percent in HIV positive populations in the United States and other developed countries, while in the developing world or underserved populations in the U.S. the mortality rate approaches 80 percent, she explained.

An advance in combating Pneumocystis could also help transplant patients who are on immunosuppressive drugs for life and other patients receiving these therapies for ailments such as rheumatoid arthritis, says Cushion.
-end-
Cushion is joined in this research by co-authors Aleksey Porollo, PhD, UC assistant professor in the Department of Environmental Health and a researcher for Cincinnati Children's Medical Center; Edward Merino, PhD, UC associate professor in the Department of Chemistry; Anish Kizhakkekkara Vadukoot, PhD, a former UC post-doctoral fellow; Margaret Collins, senior research assistant in the UC Department of Internal Medicine; and Thomas Sesterhenn, senior research assistant in the UC Department of Internal Medicine.

Research reported in this publication was supported by the National Heart, Lung and Blood Institute, National Institutes of Health under the award number HL119190 and by the U.S. Department of Veterans Affairs. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

University of Cincinnati Academic Health Center

Related Fungus Articles:

Taming the wild cheese fungus
The flavors of fermented foods are heavily shaped by the fungi that grow on them, but the evolutionary origins of those fungi aren't well understood.
Candida auris is a new drug-resistant fungus emerging globally and in the US early detection is key to controlling spread of deadly drug-resistant fungus
Early identification of Candida auris, a potentially deadly fungus that causes bloodstream and intra-abdominal infections, is the key to controlling its spread.
Genetic blueprint for extraordinary wood-munching fungus
The first time someone took note of Coniochaeta pulveracea was more than two hundred years ago, when the South African-born mycologist Dr Christiaan Hendrik Persoon mentioned it in his 1797 book on the classification of fungi.
How a fungus can cripple the immune system
An international research team led by Professor Oliver Werz of Friedrich Schiller University, Jena, has now discovered how the fungus knocks out the immune defenses, enabling a potentially fatal fungal infection to develop.
North American checklist identifies the fungus among us
Some fungi are smelly and coated in mucus. Others have gills that glow in the dark.
Tropical frogs found to coexist with deadly fungus
In 2004, the frogs of El Copé, Panama, began dying by the thousands.
Deadly amphibian fungus has its origins in East Asia
The fungus kills frogs, toads and salamanders, and now we know where it emerged.
How wheat can root out the take-all fungus
In the soils of the world's cereal fields, a family tussle between related species of fungi is underway for control of the crops' roots, with food security on the line.
Fungus senses gravity using gene borrowed from bacteria
The pin mold fungus Phycomyces blakesleeanus forms a dense forest of vertically growing fruiting bodies, but how does it know which way is 'up'?
Invasion of the body-snatching fungus
UConn researchers recently documented in Nature Scientific Reports a gory and fascinating relationship between periodical cicadas and a fungus that infects them, hijacks their behavior, and causes a scene straight out of a zombie movie.
More Fungus News and Fungus Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.